It looks like a solid cake or compressed powder, but at the molecular level, it is an open lattice held in a specific conformation
Its weight loss effect, however, is far less pronounced
This regenerative approach is one big reason experts wonder whether hair loss could be entering a GLP-1-type era
Key takeaways GLP-1 agonists are a class of drugs that were originally designed to treat type 2 diabetes, but their use has expanded to include weight loss, heart and kidney disease risk reduction, and management of obstructive sleep apnea
however these adverse reactions were tolerable and mostly temporary
After Eng filed the patent, he approached several pharmaceutical companies specialising in diabetes including Eli Lilly, Bristol Myers-Squibb, Sanofi, and Novo Nordisk